-
-
-
-
-
-
-
Olema Pharmaceuticals (OLMA) PT Lowered to $35 at Guggenheim
-
-
-
-
-
-
-
TD Cowen on Olema Pharmaceuticals (OLMA): 'Pala's Profile And Data Support Phase IIIs, Despite persevERA Disappointment'
-
-
-
-
-
-
-
Piper Sandler Starts Olema Pharmaceuticals (OLMA) at Overweight
-
-
-
-
-
-
-
Olema Pharmaceuticals (OLMA) PT Raised to $43 at Jefferies
-
-
-
-
-
-
-
Olema Pharmaceuticals (OLMA) PT Raised to $21 at Citi, Opens Catalyst Watch
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)
-
479,068 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


